Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (14543)	2/10/1998 8:35:00 PM
From: Hippieslayer	Read Replies (2) \| Respond to of 32384

here's another Biotech investor site that I'd like to share with all my immature friends here on Looney tune ligand. biospace.com here's an interesting story on a new protein found in "snake venom" that has shown to halt the spread of tumors. It reminded me of a guy that was profiled who is a snake handler as well as a researcher into the medical uses of snake venom. He's been injecting himself with snake venom for many many years. The guy is somewhere in his late 70's (I think) but he looks like he's at least 15 years younger. The only thing that's screwed up with his body is his hands(which are quite deformed) which have been repeatedly bitten over the years. pathfinder.com:80/living/latest/RB/1998Feb09/511.html

To: tonyt who wrote (14543)	2/10/1998 8:56:00 PM
From: Torben Noerup Nielsen	Read Replies (6) \| Respond to of 32384

Tony, >> But what is the deal with the hyperlipidemia? >> Is this also a problem with targretin? > Somehow I feel that "this will be viwed as positive news" for > Ligand. I get the distinct feeling that you are being sarcastic in the above. While I agree that Henry is likely to put the best possible spin on it (no offense intended Henry :-)), I think that the announcement is very good news indeed for LGND. Please note that the capsules are intended for treatment of the advanced forms of KS. That is, the disease has attacked internal organs so that you cannot treat it with a gel any longer. These people are going to die if nothing is done. The capsules may allow them to live a little longer or they may allow them to be more comfortable during whatever time they have left. Also, a drug with this kind of response rate against KS seems likely to have a response against other serious diseases. At least I would guess so. Oh well, we will see how the market reacts. This may not do a lot for the stock, but I suspect that an NDA will once it is submitted. And just wait to see what happens when LGND gets their first NDA approved. At this point, it is hard to see how the gel could be rejected. Cheers, Torben